Literature DB >> 14605170

Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Aimee K Zaas1, Molly Boyce, Wiley Schell, Barbara Alexander Lodge, Jackie L Miller, John R Perfect.   

Abstract

Rhodotorula infections occur among patients with immunosuppression and/or central venous catheters. Using standardized methods (NCCLS M27-A), we determined the antifungal susceptibilities of 10 Rhodotorula bloodstream infection isolates. Patient information was collected for clinical correlation. The MICs of amphotericin B and posaconazole were the lowest, and the MICs of triazoles and echinocandins were higher than those of other antifungal agents.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14605170      PMCID： PMC262498          DOI： 10.1128/JCM.41.11.5233-5235.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Rhodotorula glutinis-related meningitis.

Authors:  M Lanzafame; G De Checchi; A Parinello; M Trevenzoli; A M Cattelan
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.

Authors:  A L Barry; M A Pfaller; S D Brown; A Espinel-Ingroff; M A Ghannoum; C Knapp; R P Rennie; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Opportunistic infection with Rhodotorula in cancer patients treated by chemotherapy: two case reports.

Authors:  C Alliot; B Desablens; R Garidi; S Tabuteau
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

4.  In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Case report. Rhodotorula rubra fungaemia due to use of indwelling venous catheters.

Authors:  N Kiraz; Z Gülbas; Y Akgün
Journal:  Mycoses       Date:  2000       Impact factor: 4.377

6.  In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens.

Authors:  F Barchiesi; D Arzeni; A W Fothergill; L F Di Francesco; F Caselli; M G Rinaldi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

7.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  E S Eisenberg; B E Alpert; R A Weiss; N Mittman; R Soeiro
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

9.  Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters.

Authors:  D K Braun; C A Kauffman
Journal:  Mycoses       Date:  1992 Nov-Dec       Impact factor: 4.377

Review 10.  Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole.

Authors:  L Z Goldani; D E Craven; A M Sugar
Journal:  J Med Vet Mycol       Date:  1995 Jul-Aug
View more
  23 in total

1.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 2.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Activities of available and investigational antifungal agents against rhodotorula species.

Authors:  D J Diekema; B Petroelje; S A Messer; R J Hollis; M A Pfaller
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

5.  In vitro activity of natural honey alone and in combination with curcuma starch against Rhodotorula mucilaginosa in correlation with bioactive compounds and diastase activity.

Authors:  Moussa Ahmed; Noureddine Djebli; Saad Aissat; Baghdad Khiati; Abdelmalek Meslem; Salima Bacha
Journal:  Asian Pac J Trop Biomed       Date:  2013-09-04

6.  Rhodotorula mucilaginosa Fungemia and Pleural Tuberculosis in an Immunocompetent Patient: An Uncommon Association.

Authors:  Cláudia Pereira; Sofia Ribeiro; Virgínia Lopes; Teresa Mendonça
Journal:  Mycopathologia       Date:  2015-09-14       Impact factor: 2.574

7.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.

Authors:  Jorge Meneses Nunes; Fernando César Bizerra; Renata Carmona E Ferreira; Arnaldo Lopes Colombo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

9.  Femoral prosthesis infection by Rhodotorula mucilaginosa.

Authors:  Vincenzo Savini; Federica Sozio; Chiara Catavitello; Marzia Talia; Assunta Manna; Fabio Febbo; Andrea Balbinot; Giovanni Di Bonaventura; Raffaele Piccolomini; Giustino Parruti; Domenico D'Antonio
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

Review 10.  Rhodotorula fungemia of an intensive care unit patient and review of published cases.

Authors:  Anastasia Spiliopoulou; Evangelos D Anastassiou; Myrto Christofidou
Journal:  Mycopathologia       Date:  2012-05-11       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.